Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

Inclusion Criteria: * Females with a history of T2N0M0 breast carcinoma (tumor ≤3 cm in largest dimension) * Surgical or endoscopic segmental mastectomy or quadrantectomy (lumpectomy) * Clean surgical margins * No prosthesis in breast(s) to undergo treatment * Ability to undergo lipoaspiration * Last treatment for breast cancer ≥ 12 months prior to enrollment with absence of recurrence (patients on anti-estrogen adjuvant therapy are NOT excluded) * No evidence of recurrence of cancer based on mammogram or breast exam prior to enrollment * Objective signs of mild breast damage post Breast Conservation Therapy * Type I Cosmetic Sequelae Classification * A minimum of 1 cm of soft tissue (e.g. breast or fat) is available between the skin and chest wall at the recipient site * A minimum of two-thirds of the breast is remaining post Breast Conservation Therapy * No continuous adhesion of skin to bone \>3 cm in diameter * The volume and shape of the defect(s) must be conducive to correction during a single treatment session (maximum defect volume ≤150 mL in breast(s) to undergo treatment) Exclusion Criteria: * History of autoimmune disorder (e.g., Systemic Lupus Erythematosus \[SLE\]) * History of connective, metabolic or atrophic skin disease * History of keloid scarring * Chronic use (\>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within 15 days prior to enrollment * Life expectancy ≤ 2 years * Recurrence or active malignancy requiring radiation or surgical treatment ≤12 months prior to enrollment * Presence of any other known malignancy * Body Mass Index (BMI) \>30 * Plan to undergo weight reduction surgery or foresee any significant weight changes during the study (defined as changes in BMI \>5 compared to baseline * Presence of contraindications to MRI